AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Marinomed Biotech AG

Major Shareholding Notification Oct 22, 2020

749_mrq_2020-10-22_0afb13f6-e216-4ada-93f1-616c7738e68f.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

publication: 22.10.2020 16:00 source: http://adhoc.pressetext.com/news/1603375200007 keywords: Company / Voting rights / Marinomed Biotech AG

Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Marinomed Biotech AG: Release according to art. 135 section 2 BörseG

Vienna (pta033/22.10.2020/16:00) - Release of Announcement according to art. 135 section 2 BörseG

Notification of Major Holdings

1. Issuer:

Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification:

Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation

Name: Erste Asset Management GmbH

City and country of registered office: Vienna, Austria

  1. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3

5. Date on which threshold was crossed or reached

20.10.2020

6. Total positions

% of voting rights
attached to shares
(total of 7.a.)
% of voting rights
through instruments
(total of 7.b.1 +
7.b.2)
total of both in %
(7.a. + 7.b.)
total number of
voting rights of
issuer
Resulting situation
on the date on
which threshold
was crossed /
reached
10.32 0.00 10.32 1,472,034
Position of previous
notification
7.71 7.71

7. Notified details of the resulting situation

7.a. Voting rights attached to shares

ISIN code absolute direct (Sec
130 BörseG 2018)
absolute indirect
(Sec 133 BörseG
2018)
in % direct (Sec
130 BörseG 2018)
in % indirect (Sec
133 BörseG 2018)
ATMARINOMED6 151,850 0 10.32 0.00
Total: 151,850 10.32

7.b.1. Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument Expiration Date Exercise Period Voting Rights
Absolute
Voting Rights in %
Total:

7.b.2 Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

Type of Expiration Date Exercise Period Physical /Cash Voting Rights Voting Rights in
instrument Settlement Absolute %
Total:

8. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

No. Name Directly Shares held Financial/other Total of both
controlled by directly (%) instruments (%)
No. held directly (%)

9. In case of proxy voting

Date of general meeting: N/A

10. Additional Information

The voting rights held by Erste Asset Management GmbH as stated in section 8 are not held directly but by the investment funds managed by the management company. They are therefore not holdings of the management company.

emitter: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
contact person: Dr. Eva Prieschl-Grassauer
phone: +43 2262 90300
e-mail: [email protected]
website: www.marinomed.com
ISIN(s): ATMARINOMED6 (share)
stock exchanges: official trade in Vienna

News transmitted by pressetext.adhoc. The emitter is responsible for the content.

Talk to a Data Expert

Have a question? We'll get back to you promptly.